Wells Fargo & Company Cidara Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $410 Billion
  • Q1 2024

A detailed history of Wells Fargo & Company transactions in Cidara Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 643 shares of CDTX stock, worth $8,159. This represents 0.0% of its overall portfolio holdings.

Number of Shares
643
Previous 633 1.58%
Holding current value
$8,159
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$0.64 - $0.92 $6 - $9
10 Added 1.58%
643 $0
Q4 2023

Feb 09, 2024
BUY
$0.68 - $0.97 $23 - $32
34 Added 5.68%
633 $0
Q3 2023

Nov 13, 2023
BUY
$0.77 - $1.16 $21 - $32
28 Added 4.9%
599 $0
Q2 2023

Aug 15, 2023
BUY
$1.01 - $1.42 $136 - $191
135 Added 30.96%
571 $0
Q1 2023

May 12, 2023
BUY
$0.75 - $1.98 $5 - $13
7 Added 1.63%
436 $0
Q4 2022

Feb 13, 2023
BUY
$0.48 - $0.76 $9 - $15
20 Added 4.89%
429 $0
Q3 2022

Nov 14, 2022
BUY
$0.45 - $0.81 $5 - $9
12 Added 3.02%
409 $0
Q2 2022

Aug 12, 2022
BUY
$0.43 - $0.91 $18 - $40
44 Added 12.46%
397 $0
Q1 2022

May 16, 2022
BUY
$0.67 - $1.39 $0 - $1
1 Added 0.28%
353 $0
Q4 2021

Feb 14, 2022
BUY
$1.18 - $2.18 $132 - $244
112 Added 46.67%
352 $0
Q3 2021

Nov 15, 2021
SELL
$1.48 - $2.35 $44 - $70
-30 Reduced 11.11%
240 $1,000
Q2 2021

Aug 16, 2021
SELL
$1.87 - $2.7 $20,626 - $29,781
-11,030 Reduced 97.61%
270 $1,000
Q1 2021

May 13, 2021
SELL
$2.06 - $3.01 $131,796 - $192,576
-63,979 Reduced 84.99%
11,300 $30,000
Q4 2020

Feb 09, 2021
SELL
$1.99 - $3.25 $37,505 - $61,252
-18,847 Reduced 20.02%
75,279 $150,000
Q3 2020

Nov 05, 2020
BUY
$2.85 - $4.1 $93,212 - $134,094
32,706 Added 53.25%
94,126 $268,000
Q2 2020

Aug 13, 2020
BUY
$2.39 - $4.0 $142,800 - $238,996
59,749 Added 3575.64%
61,420 $227,000
Q1 2020

May 14, 2020
BUY
$1.74 - $4.26 $2,907 - $7,118
1,671 New
1,671 $4,000

Others Institutions Holding CDTX

# of Institutions
52
Shares Held
22.1M
Call Options Held
2.7K
Put Options Held
100
View Full List

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $889M
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email